Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-09-10 , DOI: 10.1111/apt.18209
Stuart McPherson _{1,

2,

3} , Jessica K Dyson _{1,

2,

3} , Laura Jopson ₁ , Steven Masson _{1,

2,

3} , Preya Patel ₁ , Quentin M Anstee _{1,

2,

3}

Affiliation

LINKED CONTENTThis article is linked to McPherson et al papers. To view these articles, visit https://doi.org/10.1111/apt.18061 and https://doi.org/10.1111/apt.18171.

中文翻译：

信件：超越晚期纤维化——评估 NIT 在识别 F2-F3 纤维化方面的性能的迫切需求。作者回复

链接内容本文与 McPherson 等人的论文相关联。要查看这些文章，请访问 https://doi.org/10.1111/apt.18061 和 https://doi.org/10.1111/apt.18171。

更新日期：2024-09-10

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南